Anavex Life Sciences Corp. (NASDAQ:$AVXL) is sitting at $4.74 with a low of $4.70 and a high of $4.95 today. According to such statistics, Anavex is the most volatile stock of the day.
Specifically, Anavex Life Sciences Corp launched on January 23, 2004, and is a clinical-stage biopharmaceutical company. It focuses on the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer’s disease, other central nervous system diseases, pain and various types of cancer. So far, it possesses a clinical drug candidate and various compounds in different stages of a preclinical study.
Traders are more bullish on Anavex shares if taking into account the decrease in short interest. The firm saw a fall in short interest of -20.06% between September 15, 2017, and September 29th, 2017. Particularly, short interest had decreased 1,051,739 over that period.
Recently, President and CEO of Anavex, Christopher U. Missling, purchased 375 shares at an average price of $4.92 on October 24th. That means, he now owns $4,978,425 of the stock.
As of September 30th. 2016, however, the company had not generated any revenues from its operations.
Featured Image: twitter
